Viewing Study NCT01111604


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2025-12-28 @ 12:38 PM
Study NCT ID: NCT01111604
Status: COMPLETED
Last Update Posted: 2019-08-06
First Post: 2010-04-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Ramucirumab or Icrucumab in Colorectal Cancer
Sponsor: Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-08
Start Date Type: None
Primary Completion Date: 2013-12
Primary Completion Date Type: ACTUAL
Completion Date: 2013-12
Completion Date Type: ACTUAL
First Submit Date: 2010-04-08
First Submit QC Date: None
Study First Post Date: 2010-04-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-06-13
Results First Submit QC Date: None
Results First Post Date: 2019-08-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2010-09-01
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2019-07-15
Last Update Post Date: 2019-08-06
Last Update Post Date Type: ACTUAL